In this episode, our guest is Josh Hattem discussing insights from recent research on the value of focus in portfolio strategy for biopharmaceutical companies. Highlights from the episode include:

- Defining what is a portfolio strategy within a biopharmaceutical company

- Why focus can provide a competitive edge but companies often fail to maximize the benefits

- Implications on how to align R&D and commercial strategy to drive pipeline investment and greater commercial success 

Additional details – Article published on InVivo (March 2021) https://invivo.pharmaintelligence.informa.com/IV124716/The-Value-And-Challenge-Of-Focus-In-Pharma

Hosted by: Jennifer Curtis

Produced by: Matilda Males

Featuring: Joshua Hattem